Linagliptin 5 mg Tablets (Linagliptin)

Adult dosage

The recommended dosage for this medication is 5 mg once daily. It can be administered without regard to meals.

This medication should not be used by individuals who are allergic to any of its components, including the active ingredient. It is also not indicated for patients with type 1 diabetes or diabetic ketoacidosis. When used in conjunction with insulin or sulfonylureas, which can induce hypoglycemia, there may be an increased risk of hypoglycemia, thus dose adjustments may be necessary. Caution should be exercised when administering to patients with heart failure, and if symptoms of acute pancreatitis develop, the medication should be discontinued immediately. If symptoms such as persistent, severe abdominal pain resembling pancreatitis or skin abnormalities like vesicular pemphigoid occur during treatment, immediate consultation with a physician is required. This medication is primarily used for the treatment of type 2 diabetes, and adverse reactions such as hypoglycemia, gastrointestinal disturbances, and skin rash have been reported in clinical trials. Particularly, hypoglycemia may occur more frequently when taken with metformin or sulfonylureas. Use in pregnant or nursing women is not recommended, and safety and efficacy have not been sufficiently established in children and adolescents, thus it is not recommended for them. Elderly patients as well as those with compromised kidney or liver function can use this medication without special dose adjustments. In cases of overdose, general supportive measures are required, including removing any unabsorbed drug from the gastrointestinal tract and monitoring symptoms. This medication should be stored out of reach of children, and transferring it to another container is not advisable as it may affect the quality.

Serious side effects

• Hives
• angioedema
• pancreatitis
• vesicular pemphigoid
• chest discomfort
• difficulty breathing
• chest pain
• death
• severe allergic reactions
• heart failure

Mild side effects

Hypoglycemia, nasopharyngitis, hypersensitivity, cough, constipation, oral ulcer formation, rash, musculoskeletal and connective tissue disorders, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is best to store it at room temperature, between 1°C and 30°C. Storing it this way helps maintain the efficacy and safety of the medication.

Appearance

Round, biconvex, bright red film-coated tablet with sharp edges on the square sides

Package unit

30 tablets (10 tablets/PTP x 3)